Arthur H. Tinkelenberg
Directeur/Membre du Conseil chez New York Biotechnology Association, Inc.
Profil
Arthur H.
Tinkelenberg was the founder of Enumeral Biomedical Holdings, Inc. (founded in 2009) where he held the title of Director in 2016.
He currently holds the position of Director at New York Biotechnology Association, Inc. Dr. Tinkelenberg's former positions include President, Chief Executive Officer & Director at Enumeral Biomedical Corp., and Director at Crosstrees Medical, Inc., Ouroboros Medical, Inc., TargAnox, Inc., Xlumena, Inc., and Metronome Therapeutics, Inc. He also held the title of Research Scientist at The Trustees of Columbia University in The City of New York and Venture Partner at ABV LLC.
Dr. Tinkelenberg received his undergraduate degree from Grinnell College and his doctorate from The Rockefeller University.
Postes actifs de Arthur H. Tinkelenberg
| Sociétés | Poste | Début |
|---|---|---|
New York Biotechnology Association, Inc.
 New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Anciens postes connus de Arthur H. Tinkelenberg
| Sociétés | Poste | Fin |
|---|---|---|
| ENUMERAL BIOMEDICAL HOLDINGS INC | Fondateur | 19/09/2016 |
Enumeral Biomedical Corp.
 Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Enumeral Biomedical Corp. develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Its proprietary micro engraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The company was founded in 2009 by J. Christopher Love, Emanuele Ostuni and Barry Buckland and is headquartered in New York, NY. | Directeur Général | - |
Xlumena, Inc.
 Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Directeur/Membre du Conseil | - |
TargAnox, Inc.
 TargAnox, Inc. Pharmaceuticals: MajorHealth Technology TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
| The Trustees of Columbia University in The City of New York | Directeur Technique/Scientifique/R&D | - |
Formation de Arthur H. Tinkelenberg
| The Rockefeller University | Doctorate Degree |
| Grinnell College | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
ABV LLC
 ABV LLC Investment ManagersFinance ABV LLC(Ascent Biomedical) is a venture capital firm founded in 2004 by Steven I Hochberg, Geoffrey W Smith and Steve Hochberg. The firm is headquartered in New York. | Finance |
Crosstrees Medical, Inc.
 Crosstrees Medical, Inc. Medical SpecialtiesHealth Technology Crosstrees Medical, Inc. develops medical devices for the spine fracture treatment. The firm focuses on percutaneous vertebral augmentation to control bone cement delivery and decrease cement leakage associated with vertebroplasty and kyphoplasty, the surgical treatments for vertebral compression fractures. The company was founded in 2003 and is headquartered in Boulder, CO. | Health Technology |
Ouroboros Medical, Inc.
 Ouroboros Medical, Inc. Medical SpecialtiesHealth Technology Ouroboros Medical, Inc. provides medical devices for the treatment of spine diseases. The company was founded in 2007 and is headquartered in Pleasanton, CA. | Health Technology |
Metronome Therapeutics, Inc.
 Metronome Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Metronome Therapeutics, Inc. manufactures and markets oncology drugs. It specializes in developing turnkey finished dosage forms of generic and drugs and has an affiliate assist producers of drugs in the diversification of their product portfolios. The company was founded by George Tidmarsh on January 13, 2006 and is headquartered in Delaware. | Health Technology |
Xlumena, Inc.
Xlumena, Inc. Medical SpecialtiesHealth Technology Xlumena, Inc. operates as a medical device company. The company was founded by Kenneth F. Binmoeller in 2004 and is headquartered in Mountain View, CA. | Health Technology |
TargAnox, Inc.
TargAnox, Inc. Pharmaceuticals: MajorHealth Technology TargAnox, Inc. develops therapeutics to prevent oxidative stress diseases. Its products are used for the treatment of diseases and conditions that result from oxidative stress-induced modification of proteins. The company was founded by Joseph Loscalzo and L. Gordon Letts in 2008 and is headquartered in New York, NY. | Health Technology |
Enumeral Biomedical Corp.
Enumeral Biomedical Corp. Miscellaneous Commercial ServicesCommercial Services Enumeral Biomedical Corp. develops monoclonal antibodies for diagnosis and treatment of infectious, autoimmune and inflammatory diseases. Its proprietary micro engraving technology creates spatially-registered, high-density bio-chip microarrays of the secreted products of single human cells derived from patient samples to provide rapid and simultaneous analysis of antibody affinity and specificity as well as cytokine profiles and T-cell functionality. The company was founded in 2009 by J. Christopher Love, Emanuele Ostuni and Barry Buckland and is headquartered in New York, NY. | Commercial Services |
New York Biotechnology Association, Inc.
New York Biotechnology Association, Inc. Miscellaneous Commercial ServicesCommercial Services New York Biotechnology Association, Inc. promotes the biotechnology industry. It supports the development and growth of New York State''s life science industry, and serves its members and the life science community by providing a network for public policy, industry advocacy, and community development. The company is headquartered in New York, NY. | Commercial Services |
Enumeral Biomedical Holdings, Inc.
 Enumeral Biomedical Holdings, Inc. BiotechnologyHealth Technology Enumeral Biomedical Holdings, Inc. is a biopharmaceutical company, which engages in the business of discovering and developing novel antibody immunotherapies for the treatment of cancer and other diseases. It also focuses on the development of a pipeline of next generation monoclonal antibody drugs targeting established and novel immuno-modulatory receptors. The company was founded by Barry C. Buckland, John J. Rydzewski, and Arthur H. Tinkelenberg on December 11, 2009 and is headquartered in Arlington, MA. | Health Technology |
